Corcept Therapeutics Inc (CORT.OQ)
CORT.OQ on NASDAQ Stock Exchange Capital Market
12.07USD
22 Oct 2018
12.07USD
22 Oct 2018
Change (% chg)
-- (--)
-- (--)
Prev Close
$12.07
$12.07
Open
--
--
Day's High
--
--
Day's Low
--
--
Volume
--
--
Avg. Vol
376,116
376,116
52-wk High
$25.92
$25.92
52-wk Low
$11.55
$11.55
About
Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The Company is developing mifepristone, a compound that modulates the effects of cortisol by acting as a competitive... (more)
Overall
| Beta: | 2.07 |
| Market Cap(Mil.): | $2,309.91 |
| Shares Outstanding(Mil.): | 113.40 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CORT.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 101.94 | 30.90 | 33.64 |
| EPS (TTM): | 0.20 | -- | -- |
| ROI: | 50.69 | 14.75 | 14.27 |
| ROE: | 52.76 | 16.24 | 15.99 |
BRIEF-Corcept Therapeutics Reports Qtrly Revenue $57.7 Million
* CORCEPT THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Estimates